CA2824591C - High protein nutritional compositions and methods of making and using same - Google Patents

High protein nutritional compositions and methods of making and using same Download PDF

Info

Publication number
CA2824591C
CA2824591C CA2824591A CA2824591A CA2824591C CA 2824591 C CA2824591 C CA 2824591C CA 2824591 A CA2824591 A CA 2824591A CA 2824591 A CA2824591 A CA 2824591A CA 2824591 C CA2824591 C CA 2824591C
Authority
CA
Canada
Prior art keywords
protein
omega
source
patient
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2824591A
Other languages
English (en)
French (fr)
Other versions
CA2824591A1 (en
Inventor
Norman Alan Greenberg
Doug Bolster
Zamzam Kabiry ROUGHEAD (Fariba)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45554910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2824591(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Publication of CA2824591A1 publication Critical patent/CA2824591A1/en
Application granted granted Critical
Publication of CA2824591C publication Critical patent/CA2824591C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA2824591A 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same Active CA2824591C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
US61/438,804 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Publications (2)

Publication Number Publication Date
CA2824591A1 CA2824591A1 (en) 2012-08-09
CA2824591C true CA2824591C (en) 2019-02-05

Family

ID=45554910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2824591A Active CA2824591C (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Country Status (14)

Country Link
US (1) US9930908B2 (enExample)
EP (1) EP2670262B2 (enExample)
JP (1) JP6034805B2 (enExample)
CN (1) CN103347403B (enExample)
AU (3) AU2012212591A1 (enExample)
BR (1) BR112013019677B1 (enExample)
CA (1) CA2824591C (enExample)
ES (1) ES2882806T3 (enExample)
MX (1) MX2013009007A (enExample)
PH (1) PH12013501433A1 (enExample)
RU (1) RU2013140443A (enExample)
SG (1) SG191428A1 (enExample)
WO (1) WO2012106179A1 (enExample)
ZA (1) ZA201306543B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013019677B1 (pt) 2011-02-02 2019-10-08 Société des Produits Nestlé S.A. Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
MX2015011771A (es) 2013-03-08 2016-12-07 Axiom Foods Inc Suplemento de proteínas de arroz y métodos de uso de este.
EP3082465A2 (en) * 2013-12-19 2016-10-26 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US20190374569A1 (en) * 2018-06-12 2019-12-12 Richard Laver Intact pea protein-based nutrient composition
CA3099923A1 (en) * 2018-06-14 2019-12-19 Mars, Incorporated Composition for supporting animal with cancer
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
JP7682790B2 (ja) 2018-11-20 2025-05-26 フォンテラ コ－オペレイティブ グループ リミティド 乳製品およびプロセス
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
AU2020284169A1 (en) * 2019-05-31 2021-10-28 Societe Des Produits Nestle Sa MCT-based nutrition blend for providing health benefits in animals
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
DE69525150T2 (de) 1994-04-01 2002-09-05 Abbott Laboratories, Abbott Park Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
AU759641B2 (en) 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
US20030055023A1 (en) * 2001-03-20 2003-03-20 Rajewski Roger A. Formulations containing etomidate and a sulfoalkyl ether cyclodextrin
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
JP4699901B2 (ja) * 2003-09-02 2011-06-15 ジェレックスインターナショナル株式会社 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1771091B1 (en) * 2004-07-01 2017-11-08 Nestec S.A. Canine osteoarthritis diet formulation
KR101075816B1 (ko) * 2004-09-22 2011-10-25 아지노모토 가부시키가이샤 종합 경장 영양 조성물
MX2008002701A (es) 2005-08-26 2008-03-18 Nestec Sa Nutricion para pacientes obesos.
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1971230A2 (en) 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
BRPI0621481A2 (pt) * 2006-03-23 2011-12-13 Nestec Sa suplemento nutricional de alta caloria
GB0612671D0 (en) 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
PT2374452T (pt) 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
BR112013019677B1 (pt) 2011-02-02 2019-10-08 Société des Produits Nestlé S.A. Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3

Also Published As

Publication number Publication date
RU2013140443A (ru) 2015-03-10
US9930908B2 (en) 2018-04-03
BR112013019677A2 (pt) 2017-03-21
BR112013019677B1 (pt) 2019-10-08
CN103347403B (zh) 2016-04-20
ZA201306543B (en) 2015-03-25
US20140308390A1 (en) 2014-10-16
ES2882806T3 (es) 2021-12-02
AU2017225011A1 (en) 2017-09-28
AU2016201327A1 (en) 2016-03-17
EP2670262B1 (en) 2021-06-30
EP2670262B2 (en) 2025-10-15
WO2012106179A1 (en) 2012-08-09
CA2824591A1 (en) 2012-08-09
CN103347403A (zh) 2013-10-09
AU2017225011B2 (en) 2019-07-18
JP2014505702A (ja) 2014-03-06
PH12013501433A1 (en) 2013-09-09
MX2013009007A (es) 2013-08-29
SG191428A1 (en) 2013-08-30
EP2670262A1 (en) 2013-12-11
AU2012212591A1 (en) 2013-07-25
JP6034805B2 (ja) 2016-11-30

Similar Documents

Publication Publication Date Title
AU2017225011B2 (en) High protein nutritional compositions and methods of making and using same
US9538778B2 (en) Stable thickener formulations
CA2830970A1 (en) Nutritional compositions including branched chain fatty acids and methods of using same
US20130210715A1 (en) Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161221